Published in Acta Crystallogr Sect F Struct Biol Cryst Commun on February 10, 2006
Solvent content of protein crystals. J Mol Biol (1968) 106.07
Superantigens - powerful modifiers of the immune system. Mol Med Today (2000) 1.43
The crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens. J Biol Chem (2005) 1.37
Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett (2003) 1.34
Microbial superantigens: from structure to function. Trends Microbiol (2000) 1.31
Interplay between superantigens and immunoreceptors. Scand J Immunol (2004) 1.11
Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol (2003) 0.99
Superantigens: the good, the bad, and the ugly. Exp Biol Med (Maywood) (2001) 0.99
Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex. Structure (2004) 0.99
Crystal and solution structures of a superantigen from Yersinia pseudotuberculosis reveal a jelly-roll fold. Structure (2004) 0.96
Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40
Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.06
Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J Infect Dis (2005) 1.92
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Antimicrob Agents Chemother (2008) 1.74
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. Cancer Immunol Immunother (2006) 1.59
A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell (2007) 1.51
Single-step Strep-tag purification for the isolation and identification of protein complexes from mammalian cells. Proteomics (2005) 1.45
Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest (2005) 1.44
The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase. J Infect Chemother (2002) 1.41
Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol (2006) 1.40
Multilocus sequence typing (MLST) for characterization of Enterobacter cloacae. PLoS One (2013) 1.39
Identification and characterization of two novel staphylococcal enterotoxins, types S and T. Infect Immun (2008) 1.38
Gasp, a Grb2-associating protein, is critical for positive selection of thymocytes. Proc Natl Acad Sci U S A (2009) 1.37
Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents. J Med Chem (2006) 1.30
Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrob Agents Chemother (2005) 1.25
Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol (2007) 1.22
Complete genome sequence of Melissococcus plutonius ATCC 35311. J Bacteriol (2011) 1.21
Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun (2005) 1.21
Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS). BMC Genomics (2011) 1.19
FtsZ: a novel target for tuberculosis drug discovery. Curr Top Med Chem (2007) 1.18
Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol (2003) 1.18
Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus. Biochemistry (2008) 1.13
Rapid awareness and transmission of severe acute respiratory syndrome in Hanoi French Hospital, Vietnam. Am J Trop Med Hyg (2005) 1.12
Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate. J Infect Dis (2006) 1.12
Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan. Microbiol Immunol (2005) 1.11
Dissemination of multidrug-resistant Klebsiella pneumoniae clinical isolates with various combinations of carbapenemases (NDM-1 and OXA-72) and 16S rRNA methylases (ArmA, RmtC and RmtF) in Nepal. Int J Antimicrob Agents (2013) 1.10
Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J Med Microbiol (2005) 1.10
Characterization of novel staphylococcal enterotoxin-like toxin type P. Infect Immun (2005) 1.09
Molecular epidemiology of Rhodococcus equi of intermediate virulence isolated from patients with and without acquired immune deficiency syndrome in Chiang Mai, Thailand. J Infect Dis (2003) 1.07
Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci. J Infect Dis (2003) 1.06
NDM-8 metallo-β-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrob Agents Chemother (2013) 1.03
"Syndromic surveillance within a hospital" for the early detection of a nosocomial outbreak of acute respiratory infection. Jpn J Infect Dis (2006) 1.02
Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital. J Infect Chemother (2007) 1.02
Complete genome sequence of highly multidrug-resistant Pseudomonas aeruginosa NCGM2.S1, a representative strain of a cluster endemic to Japan. J Bacteriol (2011) 1.02
Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother (2014) 1.01
Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol (2003) 0.99
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2010) 0.99
A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses. Int Immunol (2002) 0.99
Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS One (2011) 0.99
Development of an immunochromatographic assay for the rapid detection of AAC(6')-Iae-producing multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother (2010) 0.98
Complete genome sequence of Streptococcus pyogenes M1 476, isolated from a patient with streptococcal toxic shock syndrome. J Bacteriol (2012) 0.97
Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells. Emerg Infect Dis (2003) 0.97
Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454). Antimicrob Agents Chemother (2005) 0.96
Development of an immunochromatographic assay specifically detecting pandemic H1N1 (2009) influenza virus. J Clin Microbiol (2010) 0.96
Emetic potentials of newly identified staphylococcal enterotoxin-like toxins. Infect Immun (2013) 0.95
Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae. Infect Immun (2007) 0.95
Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect Immun (2007) 0.95
Characterization of a trinucleotide repeat sequence (CGG)5 and potential use in restriction fragment length polymorphism typing of Mycobacterium tuberculosis. J Clin Microbiol (2004) 0.95
Complete annotated genome sequence of Mycobacterium tuberculosis Erdman. J Bacteriol (2012) 0.95
ACE1 polymorphism and progression of SARS. Biochem Biophys Res Commun (2004) 0.95
Identification of mutations involved in the requirement of potassium for growth of typical Melissococcus plutonius strains. Appl Environ Microbiol (2013) 0.94
Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo-β-lactamases that mediate carbapenem resistance in Pseudomonas. J Microbiol Methods (2011) 0.93
Evolutionary paths of streptococcal and staphylococcal superantigens. BMC Genomics (2012) 0.93
Genome sequence of clinical isolate Mycobacterium tuberculosis NCGM2209. J Bacteriol (2011) 0.92
Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis. J Rheumatol (2003) 0.92
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2009) 0.92
Prevalence of erythromycin-, tetracycline-, and aminoglycoside- resistance genes in methicillin-resistant Staphylococcus aureus in hospitals in Tokyo and Kumamoto. Jpn J Infect Dis (2004) 0.92
Biological properties of staphylococcal enterotoxin-like toxin type R. Infect Immun (2004) 0.92
A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria. Lab Invest (2010) 0.91
Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan. Int J Antimicrob Agents (2012) 0.91
novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2012) 0.91
Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells. Int Immunol (2006) 0.90
IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (2013) 0.90
Akt is a neutral amplifier for Th cell differentiation. J Biol Chem (2004) 0.90
Complete genome sequence of Streptococcus dysgalactiae subsp. equisimilis 167 carrying Lancefield group C antigen and comparative genomics of S. dysgalactiae subsp. equisimilis strains. Genome Biol Evol (2013) 0.90
Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol (2011) 0.90
Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2012) 0.89
Continuous exposure of mice to superantigenic toxins induces a high-level protracted expansion and an immunological memory in the toxin-reactive CD4+ T cells. J Immunol (2002) 0.89
Dissection and identification of regions required to form pseudoparticles by the interaction between the nucleocapsid (N) and membrane (M) proteins of SARS coronavirus. Virology (2008) 0.89
Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest (2010) 0.88
Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan. J Infect Chemother (2012) 0.87
Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with acquired immune deficiency syndrome and prevalence of virulent R. equi in soil collected from domestic animal farms in Chiang Mai, Thailand. Am J Trop Med Hyg (2002) 0.87
Contrasting contributions of complementarity-determining region 2 and hypervariable region 4 of rat BV8S2+ (Vbeta8.2) TCR to the recognition of myelin basic protein and different types of bacterial superantigens. Int Immunol (2004) 0.87
Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice. Microbiol Immunol (2002) 0.86
Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother (2006) 0.86
Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol (2008) 0.86
Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol (2010) 0.86
Concomitant regulation of host tissue-destroying virulence factors and carbohydrate metabolism during invasive diseases induced by group g streptococci. J Infect Dis (2013) 0.85
Complete genome sequence of Melissococcus plutonius DAT561, a strain that shows an unusual growth profile and is representative of an endemic cluster in Japan. J Bacteriol (2012) 0.85
Loop-mediated isothermal amplification assays for identification of antiseptic- and methicillin-resistant Staphylococcus aureus. J Microbiol Methods (2010) 0.85
Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Intern Med (2012) 0.84
A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. Mol Microbiol (2014) 0.84
Maturation of adult peripheral blood CD38(+)CD4(+) T cells demonstrated by cytokine production in response to a superantigen, TSST-1. Cell Immunol (2003) 0.84
Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model. J Infect Dis (2011) 0.84
Structure-activity relationship study of taxoids for their ability to activate murine macrophages as well as inhibit the growth of macrophage-like cells. Bioorg Med Chem (2003) 0.84